HK Stock MarketDetailed Quotes

02367 GIANT BIOGENE

Watchlist
  • 47.100
  • -0.200-0.42%
Market Closed Apr 19 16:08 CST
46.86BMarket Cap29.25P/E (TTM)

GIANT BIOGENE Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Turnover
49.05%3.52B
--1.61B
52.30%2.36B
30.41%1.55B
24.44%1.19B
--956.7M
Operating income
49.05%3.52B
1.61B
52.30%2.36B
30.41%1.55B
24.44%1.19B
956.7M
Cost of sales
-56.28%-577.01M
---254.7M
-86.33%-369.21M
-8.04%-198.15M
-14.64%-183.41M
---159.99M
Operating expenses
-56.28%-577.01M
-254.7M
-86.33%-369.21M
-8.04%-198.15M
-14.64%-183.41M
-159.99M
Gross profit
47.71%2.95B
1.35B
47.32%2B
34.48%1.35B
26.40%1.01B
796.71M
Selling expenses
-64.86%-1.16B
---555.18M
-104.03%-706.37M
-118.54%-346.21M
-68.91%-158.42M
---93.79M
Administrative expenses
12.98%-96.66M
---47.48M
-53.68%-111.07M
-119.07%-72.27M
-14.38%-32.99M
---28.85M
Research and development expenses
-70.22%-74.97M
---34.01M
-76.50%-44.04M
-86.49%-24.95M
-17.38%-13.38M
---11.4M
Impairment and provision
214.01%700K
--332K
-88.34%-614K
-113.15%-326K
342.09%2.48M
---1.02M
-Other impairment is provision
214.01%700K
--332K
-88.34%-614K
-113.15%-326K
342.09%2.48M
---1.02M
Special items of operating profit
199.11%133.49M
--60.98M
-28.41%44.63M
-63.00%62.35M
998.29%168.49M
--15.34M
Operating profit
48.18%1.75B
775.64M
21.06%1.18B
-0.03%972.92M
43.76%973.24M
677M
Financing cost
-433.33%-112K
---57K
---21K
----
----
----
Earning before tax
48.17%1.75B
775.58M
21.05%1.18B
-0.03%972.92M
43.76%973.24M
677M
Tax
-68.53%-296.89M
---109.56M
-21.67%-176.16M
1.34%-144.79M
-44.14%-146.76M
---101.82M
After-tax profit from continuing operations
44.59%1.45B
666.02M
20.95%1B
0.20%828.13M
43.69%826.49M
575.18M
Earning after tax
44.59%1.45B
666.02M
20.95%1B
0.20%828.13M
43.69%826.49M
575.18M
Minority profit
-708.88%-3.55M
---917K
---439K
----
-99.85%35K
--22.92M
Profit attributable to shareholders
44.88%1.45B
666.94M
21.00%1B
0.20%828.13M
49.65%826.45M
552.26M
Basic earnings per share
50.51%1.49
0.67
19.28%0.99
0.00%0.83
50.91%0.83
0.55
Diluted earnings per share
51.02%1.48
0.66
18.07%0.98
0.00%0.83
50.91%0.83
0.55
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Turnover 49.05%3.52B--1.61B52.30%2.36B30.41%1.55B24.44%1.19B--956.7M
Operating income 49.05%3.52B1.61B52.30%2.36B30.41%1.55B24.44%1.19B956.7M
Cost of sales -56.28%-577.01M---254.7M-86.33%-369.21M-8.04%-198.15M-14.64%-183.41M---159.99M
Operating expenses -56.28%-577.01M-254.7M-86.33%-369.21M-8.04%-198.15M-14.64%-183.41M-159.99M
Gross profit 47.71%2.95B1.35B47.32%2B34.48%1.35B26.40%1.01B796.71M
Selling expenses -64.86%-1.16B---555.18M-104.03%-706.37M-118.54%-346.21M-68.91%-158.42M---93.79M
Administrative expenses 12.98%-96.66M---47.48M-53.68%-111.07M-119.07%-72.27M-14.38%-32.99M---28.85M
Research and development expenses -70.22%-74.97M---34.01M-76.50%-44.04M-86.49%-24.95M-17.38%-13.38M---11.4M
Impairment and provision 214.01%700K--332K-88.34%-614K-113.15%-326K342.09%2.48M---1.02M
-Other impairment is provision 214.01%700K--332K-88.34%-614K-113.15%-326K342.09%2.48M---1.02M
Special items of operating profit 199.11%133.49M--60.98M-28.41%44.63M-63.00%62.35M998.29%168.49M--15.34M
Operating profit 48.18%1.75B775.64M21.06%1.18B-0.03%972.92M43.76%973.24M677M
Financing cost -433.33%-112K---57K---21K------------
Earning before tax 48.17%1.75B775.58M21.05%1.18B-0.03%972.92M43.76%973.24M677M
Tax -68.53%-296.89M---109.56M-21.67%-176.16M1.34%-144.79M-44.14%-146.76M---101.82M
After-tax profit from continuing operations 44.59%1.45B666.02M20.95%1B0.20%828.13M43.69%826.49M575.18M
Earning after tax 44.59%1.45B666.02M20.95%1B0.20%828.13M43.69%826.49M575.18M
Minority profit -708.88%-3.55M---917K---439K-----99.85%35K--22.92M
Profit attributable to shareholders 44.88%1.45B666.94M21.00%1B0.20%828.13M49.65%826.45M552.26M
Basic earnings per share 50.51%1.490.6719.28%0.990.00%0.8350.91%0.830.55
Diluted earnings per share 51.02%1.480.6618.07%0.980.00%0.8350.91%0.830.55
Currency Unit CNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor Ernst & Young--Ernst & YoungErnst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg